CASP3 and myocardial infarction: Various pharmacological interventions such as olmesartan, simvastatin, angiotensin converting enzyme inhibitor and β‐adrenergic receptor blockers suppressed cardiac apoptosis, evidenced by decreased caspase 3 activity and further improved cardiac function after MI.33